Cheng-Han Lee

15PUBLICATIONS
197CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 31, 2026
Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Dec 22, 2025
GREB1-rearranged uterine tumour shares a common DNA methylation signature with ESR1-rearranged UTROSCT.

Cheng-Han Lee, Yow-Shan Lee, Jennifer A Bennett

|Nov 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Dale Garsed, Tibor Zwimpfer, Sian Fereday

|Sep 19, 2025
A 5-marker immunohistochemical panel of CK17, MEP1A, PAX8, SMAD4, and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma.

Astrid De Boeck, Eun Young Kang, Nicola S Meagher

|Aug 12, 2025
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype.

Marco Grillini, Jacopo Lenzi, Claudio Ceccarelli

Pageof 3

Frequent Collaborators

11 joint publications

Martin Koebel

5 joint publications

Nicola S Meagher

4 joint publications

Felix Kommoss

4 joint publications

Sian Fereday